Alpha 2.0
Login Register
» Articles » PMID: 32468710

Salvaging CNS Clinical Trials Halted Due to COVID-19

Overview
Journal CPT Pharmacometrics Syst Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2020 May 30
PMID 32468710
Citations 3
Authors
Hugo Geerts
Piet H van der Graaf
Affiliations
Soon will be listed here.
Citing Articles

Direct and indirect neurological, cognitive, and behavioral effects of COVID-19 on the healthy elderly, mild-cognitive-impairment, and Alzheimer's disease populations.

Iodice F, Cassano V, Rossini P Neurol Sci. 2021; 42(2):455-465.

PMID: 33409824 PMC: 7787936. DOI: 10.1007/s10072-020-04902-8.

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia.

Alonso-Lana S, Marquie M, Ruiz A, Boada M Front Aging Neurosci. 2020; 12:588872.

PMID: 33192483 PMC: 7649130. DOI: 10.3389/fnagi.2020.588872.

Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain.

Abdelnour C, Esteban de Antonio E, Perez-Cordon A, Lafuente A, Buendia M, Pancho A J Alzheimers Dis. 2020; 77(4):1805-1813.

PMID: 32986671 PMC: 7683041. DOI: 10.3233/JAD-200750.

References
1.
Zineh I . Quantitative Systems Pharmacology: A Regulatory Perspective on Translation. CPT Pharmacometrics Syst Pharmacol. 2019; 8(6):336-339. PMC: 6618141. DOI: 10.1002/psp4.12403. View
2.
Roberts P, Spiros A, Geerts H . A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease. Front Pharmacol. 2016; 7:6. PMC: 4735425. DOI: 10.3389/fphar.2016.00006. View
3.
Fisher P, Holst K, Mc Mahon B, Haahr M, Madsen K, Gillings N . 5-HTTLPR status predictive of neocortical 5-HT4 binding assessed with [(11)C]SB207145 PET in humans. Neuroimage. 2012; 62(1):130-6. DOI: 10.1016/j.neuroimage.2012.05.013. View
4.
Slifstein M, Kolachana B, Simpson E, Tabares P, Cheng B, DuVall M . COMT genotype predicts cortical-limbic D1 receptor availability measured with [11C]NNC112 and PET. Mol Psychiatry. 2008; 13(8):821-7. DOI: 10.1038/mp.2008.19. View
5.
Geerts H, Spiros A . Learning from amyloid trials in Alzheimer's disease. A virtual patient analysis using a quantitative systems pharmacology approach. Alzheimers Dement. 2020; 16(6):862-872. PMC: 7983876. DOI: 10.1002/alz.12082. View